Simvastatin as a Neuroprotective Treatment for Moderate Parkinson's Disease Trial Phase 2 Completed Oct. 17, 2021
Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine Trial Phase 2 Terminated Oct. 13, 2021
Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease Trial Phase 1 Completed Oct. 11, 2021
Assessment of the Rehabilitative Effects of Curved-walking Training in Stroke, Parkinson and Orthopaedic Populations Trial N/A Unknown Oct. 11, 2021
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks Trial N/A Completed Oct. 6, 2021
The Effect of Donepezil on Gait and Balance in Parkinson's Disease Trial Phase 4 Completed Oct. 4, 2021
Impulsivity and Parkinson's Disease : a Neuropsychology With Magnetic Resonance Imaging Study Trial N/A Completed Oct. 4, 2021
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease Trial N/A Terminated Oct. 3, 2021
Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease Trial N/A Completed Oct. 3, 2021
Group Therapy With Transcranial Direct Current Stimulation in Patients With Parkinson's Disease Trial N/A Unknown Sept. 30, 2021
Dual Task and Virtuality Training Innovation to Improve Balance, Posture and Gait in Patients With Parkinson Disease Trial N/A Unknown Sept. 30, 2021
Functional Exercise in Virtual Environment for Persons With Multiple Sclerosis or Parkinson's Disease Trial N/A Completed Sept. 29, 2021
Outcomes to the Nutritional Need of Patients With Parkinson's Disease Trial N/A Unknown Sept. 27, 2021